Skip to Content
William Ricke, PhD

Contact Dr. Ricke


(608) 265-3202

Wisconsin Institutes for Medical Research
1111 Highland Avenue
Madison, WI 53705

William Ricke, PhD

Associate Professor

Research Interests

Dr. Ricke’s research interests include prostate cancer.

Recent Publications
  • Lewis SR, Hedman CJ, Ziegler T, Ricke WA, Jorgensen JS. Steroidogenic factor 1 promotes aggressive growth of castration-resistant prostate cancer cells by stimulating steroid synthesis and cell proliferation. Endocrinology 2014 Feb; 155(2):358-69.
    [PubMed ID: 24265454, PMCID: 3891934]
    More Information
  • Nicholson TM, Uchtmann KS, Valdez CD, Theberge AB, Miralem T, Ricke WA. Renal capsule xenografting and subcutaneous pellet implantation for the evaluation of prostate carcinogenesis and benign prostatic hyperplasia. J Vis Exp 2013; (78):.
    [PubMed ID: 24022657, PMCID: 3856856]
    More Information
  • Nicholson TM, Sehgal PD, Drew SA, Huang W, Ricke WA. Sex steroid receptor expression and localization in benign prostatic hyperplasia varies with tissue compartment. Differentiation 2013 Apr-Jun; 85(4-5):140-9.
    [PubMed ID: 23792768, PMCID: 3729928]
    More Information
  • Ewald JA, Downs TM, Cetnar JP, Ricke WA. Expression microarray meta-analysis identifies genes associated with Ras/MAPK and related pathways in progression of muscle-invasive bladder transition cell carcinoma. PLoS ONE 2013; 8(2):e55414.
    [PubMed ID: 23383328, PMCID: 3562183]
    More Information
  • Nicholson TM, Ricke EA, Marker PC, Miano JM, Mayer RD, Timms BG, vom Saal FS, Wood RW, Ricke WA. Testosterone and 17β-estradiol induce glandular prostatic growth, bladder outlet obstruction, and voiding dysfunction in male mice. Endocrinology 2012 Nov; 153(11):5556-65.
    [PubMed ID: 22948219, PMCID: 3473198]
    More Information
  • Verdoorn BP, Feng C, Ricke WA, Sahasrabudhe DM, Kilari D, Kohli M. An observational study of plasma vascular endothelial growth factors (VEGF) A and D expression in non-localized prostate cancer. J Mens health 2012 Sep 1; 9(3):182-189.
    [PubMed ID: 24416090, PMCID: 3886726]
    More Information
  • Ricke EA, Williams K, Lee YF, Couto S, Wang Y, Hayward SW, Cunha GR, Ricke WA. Androgen hormone action in prostatic carcinogenesis: stromal androgen receptors mediate prostate cancer progression, malignant transformation and metastasis. Carcinogenesis 2012 Jul; 33(7):1391-8.
    [PubMed ID: 22535887, PMCID: 3499049]
    More Information
  • Lapek JD, McGrath JL, Ricke WA, Friedman AE. LC/LC-MS/MS of an innovative prostate human epithelial cancer (PHEC) in vitro model system. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2012 Apr 15; 893-894():34-42.
    [PubMed ID: 22425387, PMCID: 3322323]
    More Information
  • Ricke WA, Macoska JA, Cunha GR. Developmental, cellular and molecular biology of benign prostatic hyperplasia. Differentiation 2011 Nov-Dec; 82(4-5):165-7.
    [PubMed ID: 21880411, PMCID: 3415972]
    More Information
  • Cunha GR, Ricke WA. A historical perspective on the role of stroma in the pathogenesis of benign prostatic hyperplasia. Differentiation 2011 Nov-Dec; 82(4-5):168-72.
    [PubMed ID: 21723032, PMCID: 3729924]
    More Information Copyright © 2014 The Board of Regents of the University of Wisconsin System